Rights and permissions
About this article
Cite this article
Idarubicin and cytarabine effective in recurrent and refractory ALL. Inpharma Wkly. 1462, 9 (2004). https://doi.org/10.2165/00128413-200414620-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414620-00020